• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期血管外膜激活和增殖在鼠动静脉狭窄模型中的作用:干预的机会。

Early Adventitial Activation and Proliferation in a Mouse Model of Arteriovenous Stenosis: Opportunities for Intervention.

机构信息

Division of Nephrology, Department of Internal Medicine, Armed Forces Taoyuan General Hospital, Taoyuan 325, Taiwan.

Division of Nephrology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei 114, Taiwan.

出版信息

Int J Mol Sci. 2021 Nov 13;22(22):12285. doi: 10.3390/ijms222212285.

DOI:10.3390/ijms222212285
PMID:34830167
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8623099/
Abstract

BACKGROUND

Arteriovenous fistula (AVF) stenosis remains an important cause of AVF maturation failure, for which there are currently no effective therapies. We examined the pattern and phenotype of cellular proliferation at different timepoints in a mouse model characterized by a peri-anastomotic AVF stenosis.

METHODS

Standard immunohistochemical analyses for cellular proliferation and macrophage infiltration were performed at 2, 7 and 14 d on our validated mouse model of AVF stenosis to study the temporal profile, geographical location and cellular phenotype of proliferating and infiltrating cells in this model.

RESULTS

Adventitial proliferation and macrophage infiltration (into the adventitia) began at 2 d, peaked at 7 d and then declined over time. Surprisingly, there was minimal macrophage infiltration or proliferation in the neointimal region at either 7 or 14 d, although endothelial cell proliferation increased rapidly between 2 d and 7 d, and peaked at 14 d.

CONCLUSIONS

Early and rapid macrophage infiltration and cellular proliferation within the adventitia could play an important role in the downstream pathways of both neointimal hyperplasia and inward or outward remodelling.

摘要

背景

动静脉瘘(AVF)狭窄仍然是 AVF 成熟失败的一个重要原因,目前尚无有效的治疗方法。我们在一种吻合口周围动静脉瘘狭窄的小鼠模型中,研究了细胞增殖在不同时间点的模式和表型。

方法

在我们验证的动静脉瘘狭窄小鼠模型中,于术后 2、7 和 14 天进行细胞增殖和巨噬细胞浸润的标准免疫组织化学分析,以研究该模型中增殖和浸润细胞的时间进程、地理位置和细胞表型。

结果

外膜增殖和巨噬细胞浸润(进入外膜)始于术后 2 天,于第 7 天达到峰值,然后随时间下降。令人惊讶的是,无论是在第 7 天还是第 14 天,内膜区域的巨噬细胞浸润或增殖都很少,尽管内皮细胞增殖在 2 天至 7 天之间迅速增加,并在第 14 天达到峰值。

结论

外膜中的早期和快速的巨噬细胞浸润和细胞增殖可能在新生内膜增生和向内或向外重塑的下游途径中发挥重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90a/8623099/68a60bfbb968/ijms-22-12285-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90a/8623099/cb893651cbc1/ijms-22-12285-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90a/8623099/7ca7abb0b2dd/ijms-22-12285-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90a/8623099/ab644319658f/ijms-22-12285-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90a/8623099/74ff891a2ee4/ijms-22-12285-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90a/8623099/68a60bfbb968/ijms-22-12285-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90a/8623099/cb893651cbc1/ijms-22-12285-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90a/8623099/7ca7abb0b2dd/ijms-22-12285-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90a/8623099/ab644319658f/ijms-22-12285-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90a/8623099/74ff891a2ee4/ijms-22-12285-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c90a/8623099/68a60bfbb968/ijms-22-12285-g005.jpg

相似文献

1
Early Adventitial Activation and Proliferation in a Mouse Model of Arteriovenous Stenosis: Opportunities for Intervention.早期血管外膜激活和增殖在鼠动静脉狭窄模型中的作用:干预的机会。
Int J Mol Sci. 2021 Nov 13;22(22):12285. doi: 10.3390/ijms222212285.
2
Adventitial fibroblast-derived vascular endothelial growth factor promotes vasa vasorum-associated neointima formation and macrophage recruitment.外膜成纤维细胞衍生的血管内皮生长因子促进血管壁相关新生内膜形成和巨噬细胞募集。
Cardiovasc Res. 2020 Mar 1;116(3):708-720. doi: 10.1093/cvr/cvz159.
3
Arteriovenous fistula stenosis in hemodialysis patients is characterized by an increased adventitial fibrosis.血液透析患者的动静脉内瘘狭窄的特征是外膜纤维化增加。
J Nephrol. 2014 Oct;27(5):555-62. doi: 10.1007/s40620-014-0050-7. Epub 2014 Feb 27.
4
Proliferation patterns in a pig model of AV fistula stenosis: can we translate biology into novel therapies?动静脉内瘘狭窄猪模型中的增殖模式:我们能否将生物学转化为新的治疗方法?
Semin Dial. 2014 Nov-Dec;27(6):626-32. doi: 10.1111/sdi.12240. Epub 2014 May 28.
5
Adventitial transduction of lentivirus-shRNA-VEGF-A in arteriovenous fistula reduces venous stenosis formation.慢病毒-shRNA-VEGF-A在动静脉内瘘的外膜转导可减少静脉狭窄形成。
Kidney Int. 2014 Feb;85(2):289-306. doi: 10.1038/ki.2013.290. Epub 2013 Aug 7.
6
Pathogenetic role for early focal macrophage infiltration in a pig model of arteriovenous fistula (AVF) stenosis.
J Vasc Access. 2014 Jan-Feb;15(1):25-8. doi: 10.5301/jva.5000151. Epub 2013 Sep 3.
7
Adventitial injection of HA/SA hydrogel loaded with PLGA rapamycin nanoparticle inhibits neointimal hyperplasia in a rat aortic wire injury model.载有 PLGA 雷帕霉素纳米粒子的 HA/SA 水凝胶的外膜注射抑制大鼠主动脉丝损伤模型中的内膜增生。
Drug Deliv Transl Res. 2022 Dec;12(12):2950-2959. doi: 10.1007/s13346-022-01158-x. Epub 2022 Apr 4.
8
Periadventitial atRA citrate-based polyester membranes reduce neointimal hyperplasia and restenosis after carotid injury in rats.基于柠檬酸的动脉外膜全反式维甲酸聚酯膜可减少大鼠颈动脉损伤后的内膜增生和再狭窄。
Am J Physiol Heart Circ Physiol. 2014 Nov 15;307(10):H1419-29. doi: 10.1152/ajpheart.00914.2013. Epub 2014 Sep 19.
9
Adventitial delivery of nanoparticles encapsulated with 1α, 25-dihydroxyvitamin D attenuates restenosis in a murine angioplasty model.纳米颗粒包裹 1α,25-二羟维生素 D 经内膜下给药可减轻小鼠血管成形术后再狭窄。
Sci Rep. 2021 Feb 26;11(1):4772. doi: 10.1038/s41598-021-84444-x.
10
Macrophage-derived MMP-8 determines smooth muscle cell differentiation from adventitia stem/progenitor cells and promotes neointima hyperplasia.巨噬细胞衍生的 MMP-8 决定从动脉外膜干细胞/祖细胞分化为平滑肌细胞,并促进内膜增生。
Cardiovasc Res. 2020 Jan 1;116(1):211-225. doi: 10.1093/cvr/cvz044.

引用本文的文献

1
The Pathological Mechanisms and Therapeutic Molecular Targets in Arteriovenous Fistula Dysfunction.动静脉瘘功能障碍的病理机制及治疗分子靶点。
Int J Mol Sci. 2024 Sep 1;25(17):9519. doi: 10.3390/ijms25179519.
2
Molecular Mechanisms of Hemostasis, Thrombosis and Thrombo-Inflammation.止血、血栓形成和血栓炎症的分子机制。
Int J Mol Sci. 2022 May 23;23(10):5825. doi: 10.3390/ijms23105825.
3
Comparative analysis of cellular phenotypes within the neointima from vein segments collected prior to vascular access surgery and stenotic arteriovenous dialysis accesses.

本文引用的文献

1
Arteriovenous Fistula Maturation, Functional Patency, and Intervention Rates.动静脉瘘成熟度、功能通畅率和介入治疗率。
JAMA Surg. 2021 Dec 1;156(12):1111-1118. doi: 10.1001/jamasurg.2021.4527.
2
Anti Human CX3CR1 VHH Molecule Attenuates Venous Neointimal Hyperplasia of Arteriovenous Fistula in Mouse Model.抗人CX3CR1 VHH分子减轻小鼠模型动静脉内瘘的静脉内膜增生
J Am Soc Nephrol. 2021 Jul;32(7):1630-1648. doi: 10.1681/ASN.2020101458. Epub 2021 Apr 23.
3
Adventitial delivery of nanoparticles encapsulated with 1α, 25-dihydroxyvitamin D attenuates restenosis in a murine angioplasty model.
对血管通路手术前采集的静脉段和狭窄的动静脉透析通路的新生内膜内细胞表型的比较分析。
Semin Dial. 2014 May-Jun;27(3):303-9. doi: 10.1111/sdi.12172. Epub 2013 Dec 17.
纳米颗粒包裹 1α,25-二羟维生素 D 经内膜下给药可减轻小鼠血管成形术后再狭窄。
Sci Rep. 2021 Feb 26;11(1):4772. doi: 10.1038/s41598-021-84444-x.
4
1α,25-Dihydroxyvitamin D Encapsulated in Nanoparticles Prevents Venous Neointimal Hyperplasia and Stenosis in Porcine Arteriovenous Fistulas.包裹于纳米颗粒中的1α,25-二羟基维生素D可预防猪动静脉内瘘的静脉内膜增生和狭窄。
J Am Soc Nephrol. 2021 Apr;32(4):866-885. doi: 10.1681/ASN.2020060832. Epub 2021 Feb 24.
5
PATENCY-2 trial of vonapanitase to promote radiocephalic fistula use for hemodialysis and secondary patency.vonapanitase 促进头静脉内瘘用于血液透析和二级通畅的 PATENCY-2 试验。
J Vasc Access. 2022 Mar;23(2):265-274. doi: 10.1177/1129729820985626. Epub 2021 Jan 22.
6
International Comparisons of Native Arteriovenous Fistula Patency and Time to Becoming Catheter-Free: Findings From the Dialysis Outcomes and Practice Patterns Study (DOPPS).国际 natives arteriovenous 瘘通畅率和无导管时间的比较:来自透析结局和实践模式研究 (DOPPS) 的结果。
Am J Kidney Dis. 2021 Feb;77(2):245-254. doi: 10.1053/j.ajkd.2020.06.020. Epub 2020 Sep 21.
7
Challenges and novel therapies for vascular access in haemodialysis.血液透析血管通路的挑战和新疗法。
Nat Rev Nephrol. 2020 Oct;16(10):586-602. doi: 10.1038/s41581-020-0333-2. Epub 2020 Aug 24.
8
Therapeutic Effect of Adipose Derived Mesenchymal Stem Cell Transplantation in Reducing Restenosis in a Murine Angioplasty Model.脂肪间充质干细胞移植在减少小鼠血管成形术后再狭窄中的治疗效果。
J Am Soc Nephrol. 2020 Aug;31(8):1781-1795. doi: 10.1681/ASN.2019101042. Epub 2020 Jun 25.
9
Local adventitial anti-angiogenic gene therapy reduces growth of vasa-vasorum and in-stent restenosis in WHHL rabbits.局部外膜抗血管生成基因治疗可减少 WHHL 兔血管腔血管生成和支架内再狭窄。
J Mol Cell Cardiol. 2018 Aug;121:145-154. doi: 10.1016/j.yjmcc.2018.07.007. Epub 2018 Jul 9.
10
International Differences in the Location and Use of Arteriovenous Accesses Created for Hemodialysis: Results From the Dialysis Outcomes and Practice Patterns Study (DOPPS).国际间血液透析用动静脉通路位置与使用的差异:来自透析结局和实践模式研究(DOPPS)的结果。
Am J Kidney Dis. 2018 Apr;71(4):469-478. doi: 10.1053/j.ajkd.2017.09.012. Epub 2017 Dec 1.